OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

Trustees’ Annual Report for the period

From 01 January 2025 Period start date To 31 December 2025 Period end date

Charity name: Foundation for Angelman Syndrome Therapeutics UK Charity registration number: 1167984

Objectives and Activities

SORP reference
Summary of the purposes of
the charity as set out in its
governing document
Para 1.17 The objects of the CIO are:-
1. the advancement of health for the benefit
of the public by the provision of support
towards research into Angelman syndrome
including their treatment and cure, and the
publication of the useful results of such
research; and
2. the relief of those in need of care,
assistance and support as a consequence of
living with Angelman Syndrome.
Summary of the main
activities in relation to those
purposes for the public
benefit, in particular, the
activities, projects or services
identified in the accounts.
Para 1.17 and
1.19
Foundation for Angelman Syndrome
Therapeutics UK continues to assist Oxford
University in funding a Natural History Study
for Angelman Syndrome. The study has
been funded by FAST UK for 4 years and
has now been extended by another 2 years
with the recruitment of 15 more patients. As
well as this, FAST UK is funding to support
the delivery of weekend lumbar puncture
(LP) clinics as part of the Angelman
syndrome clinical research programme at
the University of Oxford.
Statement confirming
whether the trustees have
had regard to the guidance
issued by the Charity
Commission on public
benefit
Para 1.18 The trustees have had regard to the
guidance issued by the Charity Commission
on public benefit.

Additional information (optional) You may choose to include further statements where relevant about:

SORP reference Para 1.38 Policy on grant making Para 1.38

Policy on social investment including program related investment Para 1.38 Contribution made by volunteers Other

Achievements and Performance

SORP reference
Summary of the main
achievements of the charity,
identifying the difference the
charity’s work has made to
the circumstances of its
beneficiaries and any wider
benefits to society as a
whole.
Para 1.20 Fund raising activities and donations
through-out the financial period have raised
income of £29,329.
FAST UK is linked with FAST US who are
making huge steps into finding a cure for
Angelman Syndrome through scientific
research, and FAST UK have continued to
support FAST US’s efforts with this.
FAST UK has committed to fund the Natural
History Study in conjunction with Oxford
University for another 5 years with an
additional year for data analysis.
Funding of £25,732 per year will be provided
in the years 2026 to 2031 inclusive. FAST
UK have also committed to funding an AS
weekend lumbar puncture clinic to ensure
trials are kept on track and in timelines at a
cost of £108,000 over 3 years with a start
date of June 2026.
The NHS continues to be a success with
useful and meaningful data. Clinical trials are
also currently taking place in Oxford with
more pharma companies looking to start
their trials next year.

Additional information (optional) You may choose to include further statements where relevant about:

Achievements against Para 1.41 objectives set

Performance of fundraising
activities against objectives
set
Para 1.41
Investment performance
against objectives
Para 1.41
Other

Financial Review

Financial Review
Review of the charity’s
financial position at the end
of the period
Para 1.21 At the end of the period the charity was in a
net asset position of £347,206.
Statement explaining the
policy for holding reserves
stating why they are held
Para 1.22 There is no reserves policy, and no
reserves are held.
Amount of reserves held Para 1.22 Nil. Cash at year end was £347,206, none
of which is specifically held in reserves.
Reasons for holding zero
reserves
Para 1.22 The charity is small, with one employee and
has minimal fixed costs or expenses, and is
in a positive cash position and as such no
reserves are required.
Details of fund materially in
deficit
Para 1.24 N/A
Explanation of any
uncertainties about the
charity continuing as a going
concern
Para 1.23 There are no uncertainties over the charity’s
ability to continue as a going
concern. There are substantial cash
reserves to support the on-going level of
expenditure.

Additional information (optional) You may choose to include further statements where relevant about: The charity’s principal sources of funds (including Para 1.47 any fundraising) Investment policy and objectives including any Para 1.46 social investment policy adopted A description of the principal Para 1.46 risks facing the charity Other

Structure, Governance and Management

Description of charity’s
trusts:
Type of governing document
(trust deed, royal charter)
Para 1.25 Constitution
How is the charity
constituted?
(e.g unincorporated
association, CIO)
Para 1.25 A Charitable Incorporated Organisation
Trustee selection methods
including details of any
constitutional provisions e.g.
election to post or name of
any person or body entitled
to appoint one or more
trustees
Para 1.25 Apart from the first charity trustees, every
trustee must be appointed by a resolution
passed at a properly convened meeting of
the charity trustees.

Additional information (optional) You may choose to include further statements where relevant about:

Policies and procedures
adopted for the induction and
training of trustees
Para 1.51
The charity’s organisational
structure and any wider
network with which the
charity works
Para 1.51
Relationship with any related
parties
Para 1.51
Other

Reference and Administrative details

Charity name Foundation for Angelman Syndrome Therapeutics UK
Other name the charity uses FAST UK
Registered charity number 1167984
Charity’s principal address 13 Inglethorpe Street,
London,
SW6 6NS

Names of the charity trustees who manage the charity

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Trustee name Office (if any) Dates acted if not for whole
year
Nam
e of
pers
on
(or
body
)
entitl
ed to
appo
int
trust
ee (if
any)
Thomas Keogh Chair
Tamsin Keogh
Antonia Felix
Louise Prince
Katharine Hamilton
Julien de Bournet
Sarah Washbrook 16/06/2016 -present
20

– Corporate trustees names of the directors at the date the report was approved

Director name

Name of trustees holding title to property belonging to the charity

Trustee name Dates acted if not for whole year

Funds held as custodian trustees on behalf of others

Description of the assets
held in this capacity
N/A
Name and objects of the
charity on whose behalf the
assets are held and how this
falls within the custodian
charity’s objects
N/A
Details of arrangements for
safe custody and
segregation of such assets
from the charity’s own assets
N/A

Additional information (optional)

Names and addresses of advisers (Optional information)

Type of
adviser
Name
Address
Type of
adviser
Name
Address
Type of
adviser
Name
Address
Name of chief executive or names of senior staff members (Optional information)

Declarations

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees Signature(s) Full name(s) Thomas Keogh Position (eg Chair Secretary, Chair, etc) Date 26/10/2026

Charity Name No (if any) Foundation for Angelman Syndrome Therapeutics UK 1167984 Receipts and payments accounts CC16a For the period Period start date Period end date To from 01-Jan-25 31-Dec-25

Section A Receipts and payments Section A Receipts and payments
A1 Receipts Unrestricted
funds
to the nearest £
29,329
-
-
-
-
-
-
-
29,329
-
-
-
29,329
4,182
562
442
1,000
10,437
125
-
-
-
16,748
-
-
-
16,748
12,581
-
334,625
347,206
Restricted
funds
to the nearest £
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Endowment
funds
to the nearest £
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Total funds
to the nearest £
29,329
-
-
-
-
-
-
-
29,329
-
-
-
29,329
4,182
562
442
1,000
10,437
125
-
-
-
16,748
-
-
-
16,748
12,581
Last year
to the nearest £
Fundraisingand Donations 29,329 183,082
- -
- -
- -
- -
- -
- -
- -
Sub total(Gross income for
AR)
29,329 183,082
A2 Asset and investment sales,
(see table).
-
- -
~~Sub total~~ - -
Total receipts
A3 Payments
183,082
Salary,Pension and Related Expenses 4,182 10,151
Incurred raisingdonations 562 562
Marketing,Advertisingand Postage 442 1,106
Website Cost 1,000 1,000
StagingFundraisingevents 10,437 25,008
Subscriptions and Memberships 125 -
- -
- -
- -
**Sub total ** 16,748 37,827
A4 Asset and investment
purchases, (see table)
-
-
**Sub total ** - -
Total payments
Net of receipts/(payments)
A5 Transfers between funds
A6 Cash funds last year end
Cash funds this year end
37,827
12,581 - - 12,581 145,255
- - - - -
334,625 - - 334,625 189,370
347,206 - - 347,206 334,625

CCXX R1 accounts (SS)

13/10/2026

1

Section B Statement of assets and liabilities at the end of the period Section B Statement of assets and liabilities at the end of the period Section B Statement of assets and liabilities at the end of the period
Categories
Signed by one or two trustees on
behalf of all the trustees
B5 Liabilities
B3 Investment assets
B2 Other monetary assets
B4 Assets retained for the
charity’s own use
B1 Cash funds
Details
Details
Total cash funds
(agree balances with receipts and payments
account(s))
Cash at Bank
Details
Details
Details
Signature
Unrestricted
funds
Restricted
funds
to nearest £
to nearest £
347,206
-
-
-
-
-
347,206
-
OK
OK
Unrestricted
funds
Restricted
funds
to nearest £
to nearest £
-
-
-
-
-
-
-
-
-
-
-
-
Fund to which
asset belongs
Cost (optional)
-
-
-
-
-
Fund to which
asset belongs
Cost (optional)
-
-
-
-
-
-
-
-
-
Fund to which
liability relates
Amount due
(optional)
-
-
-
-
-
Print Name
Tom Keogh
Katharine Hamilton
Endowment
funds
to nearest £
-
-
-
-
OK
Endowment
funds
to nearest £
-
-
-
-
-
-
Current value
(optional)
-
-
-
-
-
Current value
(optional)
-
-
-
-
-
-
-
-
-
When due
(optional)
Date of
approval
Tom Keogh 12/10/2026
Katharine Hamilton 12/10/2026

CCXX R2 accounts (SS)

13/10/2026

2

CHARITY COMM15510NI •wnln•f• FOR ENGIAND APIO WAIES qr